Concepedia

Lulu Wang

LW

Statistics

Publications

12

Citations

1.5K

H-Index

10

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Huazhong University of Science and Technology

Tongji Hospital

Oregon Health & Science University

Union Hospital

Lulu Wang is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2017–2025

12

Publications

12

PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness

Jianfeng Shen, Wei Zhao, Zhenlin Ju et al. · Cancer Research · 2018 · 592 citations · Full text

, , +17

ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade

Jianfeng Shen, Zhenlin Ju, Zhao Wei et al. · Nature Medicine · 2018 · 571 citations

, , +16

Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors

Lulu Wang, Lin Yang, Chen Wang et al. · Journal of Clinical Investigation · 2020 · 106 citations · Full text

, , +17

Histone demethylase KDM7A is required for stem cell maintenance and apoptosis inhibition in breast cancer

Zhenzhen Meng, Ying Liu, Jie Wang et al. · Journal of Cellular Physiology · 2019 · 58 citations

, , +16

Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma—rationale for targeting <i>ARID1A</i> deficiency

Xiaochuan Dong, Shumei Song, Yuan Li et al. · Gut · 2021 · 36 citations · Full text

, , +17

1–5 of 12